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populations at risk of severe COVID-19 complicationsCOVID-19 vaccination campaigns are well underway in many
countries; however, a number of governments have committed to
vaccinating their entire adult populations before releasing pre-
purchased doses for other countries. With limited doses available
in 2021, this strategy will result in rich low-risk individuals
receiving jabs with marginal benefit ahead of frontline health
workers and high-risk populations in low-income countries.
Researchers at Northeastern University have estimated that in-
ternational cooperation to distribute available vaccine doses based
on population size and clinical need could cut global deaths by half,
in comparison with the competitive scenario wherein rich coun-
tries monopolise early doses for their own populations.1
While we recognise the domestic political imperatives at play,
the competitive atmosphere in which deals are being made by in-
dividual governments directly contravenes the spirit that is needed
to achieve a coordinated global recovery and potentially even
harms the self-interests of individual governments and their popu-
lations. As increasing numbers of vaccine candidates receive
approval, many wealthy countries are in the position of having
more doses of effective vaccines on order than are needed to vacci-
nate their own populations. The potential hoarding of vaccine or-
ders by some countries creates a number of risks, not only to
countries that are deprived of vaccines but also to countries that
hold more orders than they need.
First, failing to achieve control of COVID-19 in countries of the
Global South is likely to stymie any global economic recovery,
which from previous financial crises is recognised to be precarious
in itself. The World Bank2 among others has highlighted the need
for coordination in halting circulation of severe acute respiratory
syndrome coronavirus 2 in all regions of the world or else risk a
heavily subdued recovery. Global markets and supply chains
mean few countries can see a strong rebound alone.
Second, virologists and epidemiologists have already high-
lighted the risk of endemic circulation particularly with the poten-
tial for selective pressures of vaccines and treatments on further
mutations of the virus.3 Uncontrolled circulation in any region
of the world risks reintroduction of infection and possibly of
mutated strains that may affect virulence, vaccine efficacy or
transmissibility.
Third, adequate human resources for health are vital in respond-
ing to pandemics and in ensuring global health security, as shown
by the Ebola epidemic. Although fortunately mortality in manyhttps://doi.org/10.1016/j.puhe.2021.01.014
0033-3506/© 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rilow-income countries has been low in the first wave, the pandemic
is exacerbating existing health worker shortages. Countries such as
Niger, which has 1 doctor per 20,000 people, has had relatively few
COVID-19 deaths, but 19% of detected cases have been in health
workers.4
Finally, there is a clear question also of vaccine equity. Is it
morally justifiable to commence population-wide vaccination
drives in rich countries when health workers and vulnerable pop-
ulations in low-income countries have not been afforded access?
Do lives in one part of the world intrinsically matter more than in
another?
There is undeniably an opportunity to rebuild from this
pandemic a fairer and more just world than the one the virus first
appeared in. To do so, governments should avoid further bilateral
and direct procurement from vaccine manufacturers and instead
pool resources to achieve equitable, global distribution and deliv-
ery. This should include relinquishing any excess advance orders
for vaccines that countries no longer need.
This could include increased pledges to COVAX, the GAVI/WHO
platform for COVID-19 vaccines, distribution of existing purchases
and stock to in-need populations overseas, health system strength-
ening in low- and middle-income countries to aid vaccine delivery
and even application of World Trade Organisation (WTO) trade
rules to waive patent protection and allow generic vaccine produc-
tion at cost.
No one is safe until everyone is safe e policymakers and those
able to influence decisions surrounding vaccine procurement,
manufacturing and distribution need to understand the implica-
tions of our current strategy and see the benefits of one that better
prioritises social justice and health equity.References
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